GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 103 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $42,000 | -99.1% | 10,273 | -97.0% | 0.00% | -100.0% |
| Q4 2021 | $4,475,000 | -68.6% | 347,911 | -73.6% | 0.00% | -69.2% |
| Q3 2021 | $14,253,000 | +24.4% | 1,319,793 | +5.2% | 0.01% | +30.0% |
| Q2 2021 | $11,456,000 | +125.0% | 1,254,720 | +132.4% | 0.01% | +100.0% |
| Q1 2021 | $5,091,000 | +526.2% | 539,798 | +161.6% | 0.01% | +400.0% |
| Q4 2020 | $813,000 | +71.2% | 206,362 | +15.2% | 0.00% | – |
| Q3 2020 | $475,000 | +202.5% | 179,167 | +1668.7% | 0.00% | – |
| Q4 2018 | $157,000 | – | 10,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,102,929 | $18,059,047,000 | 4.95% |
| Svennilson Peter | 3,102,934 | $18,059,000 | 2.29% |
| Casdin Capital, LLC | 2,270,000 | $13,211,000 | 1.40% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $11,999,000 | 1.36% |
| Redmile Group, LLC | 3,068,194 | $17,857,000 | 0.50% |
| Alphabet Inc. | 929,022 | $5,407,000 | 0.36% |
| Bleichroeder LP | 169,039 | $984,000 | 0.26% |
| Leap Investments LP | 14,400 | $84,000 | 0.12% |
| DAFNA Capital Management LLC | 50,000 | $291,000 | 0.12% |
| Blackstone Inc. | 2,567,445 | $14,943,000 | 0.11% |